Medical Devices
Technology
Health

ABIOMED

$343.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.69 (1.09%) Today
+$3.69 (1.09%) Today

Why Robinhood?

You can buy or sell ABIOMED and other stocks, options, ETFs, and crypto commission-free!

About

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. Read More The company was founded in 1981 and is headquartered in Danvers, MA.

Employees
1,143
Headquarters
Danvers, Massachusetts
Founded
1981
Market Cap
15.29B
Price-Earnings Ratio
71.35
Dividend Yield
0.00
Average Volume
655.85K
High Today
$344.54
Low Today
$337.90
Open Price
$337.90
Volume
95.34K
52 Week High
$459.75
52 Week Low
$274.02

Collections

Medical Devices
Technology
Health
Medical
US
North America

News

Yahoo Finance20h

Abiomed (ABMD) Gains As Market Dips: What You Should Know

Abiomed (ABMD) closed the most recent trading day at $339.28, moving +1.81% from the previous trading session. Abiomed (ABMD) closed at $339.28 in the latest trading session, marking a +1.81% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.01%. Elsewhere, the Dow lost 0.1%, while the tech-heavy Nasdaq added 0.12%. Heading into today, shares of the maker of heart devices had lost 7.96% over the past month, lagging the Medical sector's gain of 1.11% and the S&P 500's gain of 2.24% ...

90
Seeking AlphaMar 19

Abiomed: Is This A Good Opportunity?

Abiomed Inc. (ABMD) is a leading provider of temporary mechanical circulatory support devices. The company focuses on developing, manufacturing and marketing proprietary products that are designed to enable the heart to rest, heal and recover. Besides the established business model and good products currently on the market, Abiomed’s future devices are also very interesting. This might be the reason why its valuation is now quite high. Nevertheless, the company has a huge market potential and might be an in...

184
Yahoo FinanceMar 18

Is ABIOMED (ABMD) Outperforming Other Medical Stocks This Year?

Investors focused on the Medical space have likely heard of ABIOMED (ABMD), but is the stock performing well in comparison to the rest of its sector peers?

84

Earnings

$0.38
$0.58
$0.77
$0.97
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected May 2, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.